Epigenetics: a highly promising source of new drug targets

Strategies to unlock and read the epigenetic code for a new source of therapeutics

As an introduction to the web theme issue on Epigenetics published in MedChemComm (guest-edited by Dr Mark Bunnage – Pfizer –  and Professor Rasmus Prætorius Clausen -University of Copenhagen), Nessa Carey (Head of Epigenetics ERDI, Pfizer) provides a concise summary of the current thinking in the ever expanding field of epigenetics.


Read Nessa’s review:
Epigenetics – an emerging and highly promising source of new drug targets
Nessa Carey
Med. Chem. Commun., 2012, Advance Article
DOI: 10.1039/C1MD00264C

…and view the collection of articles that makes for a timely and essential web theme issue in the emerging field of epigenetics research.

Digg This
Reddit This
Stumble Now!
Share on Facebook
Bookmark this on Delicious
Share on LinkedIn
Bookmark this on Technorati
Post on Twitter
Google Buzz (aka. Google Reader)